1. The use of methylphenidate in Michigan
- Author
-
Rappley, Marsha D., Gardiner, Joseph C., Jetton, James R., and Houang, Richard T.
- Subjects
Michigan -- Health aspects ,Attention-deficit hyperactivity disorder -- Care and treatment ,Methylphenidate hydrochloride -- Health aspects ,Health - Abstract
Objective: To describe the epidemiologic findings associated with the use of methylphenidate hydrochloride among children aged 0 to 19 years in Michigan. Design: A population-based data set of all prescriptions filed with the Michigan Triplicate Prescription Program during February and March 1992 was analyzed, maintaining complete anonymity. Setting: State of Michigan. Participants: All patients receiving a prescription for methylphenidate who are residents of Michigan, and all physicians prescribing methylphenidate. Interventions: None. Main Outcome Measures: Descriptive data. Results: Eleven of 1000 Michigan residents between the ages of 0 and 19 years received a prescription for methylphenidate during the study period. Eighty-four percent were boys. Boys aged 10 or 11 years received more prescriptions for methylphenidate than any other age group--43 per 1000. The number of children receiving prescriptions for methylphenidate ranged from 2.5 to 28 per 1000. The range for boys aged 10 or 11 years was from 9.6 to 117 per 1000. Primary care physicians wrote 84% of all prescriptions; pediatricians wrote 59% of the prescriptions for patients younger than 20 years old. Half of the prescriptions written by pediatricians were written by 5% of the pediatricians in the state. Conclusions: Michigan has been among the states with the highest per capita consumption of methylphenidate for the past 10 years. The major use of methylphenidate is for treatment of attention deficit hyperactivity disorder. The number of boys in Michigan aged 10 or 11 years who were treated with methylphenidate was similar to the national prevalence of the disorder, 3% to 5%. A tenfold variation was noted in the percentage of children medicated when the data were analyzed by county. Relatively few pediatricians account for the largest proportion of prescriptions. Future studies are needed to link the use of methylphenidate with diagnostic and treatment considerations in attention deficit hyperactivity disorder. (Arch Pediatr Adolesc Med. 1995;149:675-679), The distribution and characteristics of children taking and physicians prescribing methylphenidate hydrochloride in Michigan are described. Methylphenidate hydrochloride is the drug of choice for treating attention deficit hyperactivity disorder (ADHD). Michigan has one of the highest prescription rates of any state for this medication. Prescription records and coding were used to identify the characteristics of the children and the prescribing doctor. Overall, 11 out of every 1000 children from birth to 19 years were prescribed methylphenidate: 2% of all boys and 0.4% of all girls. Nearly half the prescriptions were written for children aged 8 to 11. The highest rate was 43 per 1000 for boys aged 10 to 11. Prescription rates varied 10-fold among counties. Eighty-four percent of prescriptions were written by pediatricians, family or general practitioners. Five percent of pediatricians and 13% of family practitioners wrote half the prescriptions. This variation in prescribing pattern may reflect doctors specializing in ADHD patients or regional variations in attitudes of teachers, parents, or doctors.
- Published
- 1995